➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Hikma Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has three hundred and forty approved drugs.

There are five US patents protecting HIKMA drugs. There are three tentative approvals on HIKMA drugs.

Drugs and US Patents for Hikma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065238-001 Mar 12, 2010 AP RX No No   Start Trial   Start Trial
Hikma Pharms PENICILLIN V POTASSIUM penicillin v potassium TABLET;ORAL 090549-002 Oct 11, 2013 AB RX No No   Start Trial   Start Trial
Hikma OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET;ORAL 090964-002 Sep 27, 2010 AB RX No No   Start Trial   Start Trial
Hikma ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 200652-001 May 4, 2015 AB RX No No   Start Trial   Start Trial
Hikma DOXERCALCIFEROL doxercalciferol CAPSULE;ORAL 091433-001 Sep 23, 2011 AB RX No No   Start Trial   Start Trial
Hikma Intl Pharms GLYCOPYRROLATE glycopyrrolate TABLET;ORAL 040836-002 Mar 5, 2009 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HIKMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 2016-06-10
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.